# Folinic Acid as a Treatment for Autism Spectrum Disorder in Children

> **NCT07630506** · PHASE2 · RECRUITING · sponsor: **KK Women's and Children's Hospital** · enrollment: 184 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** Folinic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07630506
- **Lead sponsor:** KK Women's and Children's Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-19
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-06-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630506, "Folinic Acid as a Treatment for Autism Spectrum Disorder in Children". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07630506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*